UTHR vs VC · P/E 20, rev $1.56B vs P/E 18, rev $1.91B
United Therapeutics Corporation (UTHR) versus Visteon Corp (VC) — a side-by-side from cached financials, not a winner call.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Visteon Corp (VC) is a auto parts company listed on NASDAQ.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Latest reported VC revenue for 2026-06-30 was $1.91B. Net income was $80.0M. VC currently screens at market cap $2.95B and trailing P/E 18.5.
UTHR currently screens at market cap $23.41B and trailing P/E 20.4. VC currently screens at market cap $2.95B and trailing P/E 18.5.
Not investment advice. Open the UTHR and VC stock pages for the full models.
Not investment advice.